// App-Quantinova.ai

e21148 : The detection of circulating tumor cells in patients with renal cell carcinoma using the AccuCyte platform and customized markers.

Researchers

Presenter

  • Arturo Ramirez

Principal Investigators

  • Scott S. Tykodi

  • Sherry Huang

  • Nicholas Alan Drovetto

  • Jackie L. Stilwell

Medical Centers

  • RareCyte Inc., Seattle, WA

  • Rarecyte, Seattle, WA

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Renal cell carcinoma

  • Metastatic Renal Cell Cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Carbonic anhydrase IX

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Epidermal growth factor receptor

  • Epithelial Cell Adhesion Molecule

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved